NEOPha  Pharmacovigilance Consultancy.

 

 

 

 

 

 

 

 

 

 

 

 

 

  

NEOPha provides drug safety and pharmacovigilance consulting for new pharmaceutical drugs, and nutritional supplements.

Welcome to NEOPha Inc, www.fornewdrugs.com

 

Consulting Services for New Drugs, Medical Devices, & Nutritional Supplements

The CEO & President of NEOPha Inc,  is Noumbissie Emmanuel Osong

Emmanuel is an epidemiologist with clinical research knowledge, and public health science.

EDUCATION

Walden University, PhD in Public Health – Epidemiology.

Walden University, M.P.H., Masters in Public Health, (2008).

Hood College, B.A., in Biology, (2006).

British College of Buea, B.S., in Computer Science, (2001).

PREVIOUS WORK EXPERIENCE

Z-Tech, Inc. Consultant

Technical Resources International, Inc.  Safety and Pharmacovigilance Specialist

Frederick County Public Schools. Tutor

Loudoun Prep. Tutor

SELECETED PUBLICATIONS

Emmanuel O. Noumbissie., Drug Safety Enhancement Among the Ederly with the Help of Active Surveillance Using observational Healthcare Data.  School of Health Sciences, Walden University. December 2012.

Emmanuel O. Noumbissie., Pharmacovigilance websites as a preventive tool for drug adverse experiences among the elderly.  School of Health Sciences, Walden University. December 2010.

Emmanuel O. Noumbissie., Dana G. Cable., Dementia, Ethical challenges of patient treatment and care.  Psychology and Thanatology department, Hood College. Spring 2005.


Emmanuel Noumbissie has the broad-based experience to provide comprehensive clinical and post marketed drug safety consulting services to help you address product safety concerns in a confident, proactive manner.